EPI|LIFESTYLE 2020 Scientific Sessions
Epidemiology and Prevention | Lifestyle and Cardiometabolic Health
March 3 – 6, 2020
Hyatt Regency Phoenix | Phoenix, Arizona
Abstract Submission
Abstract submission is now closed.


What's New

The EPI|Lifestyle 2020 Scientific Sessions theme is: Promoting Cardiovascular Health Across the Lifespan: How Do We Live Healthier, Longer?

Featured Session

Session 8A: "Hot Off The Press"
Thursday, March 5, 10:30 a.m. to 12:00 p.m.
Regency Ballroom

Marie-France Hivert, MD, FAHA, Harvard Medical School, Boston, Massachusetts
Mercedes Carnethon, PhD, FAHA, Northwestern University Feinberg School of Medicine, Chicago, Illinois

10:30 a.m.
Effect of Electronic Health Record-Based Coaching on Weight Maintenance: A Randomized Trial
Margaret B. Conroy, MD, MPH, FACSM, FAHA, University of Utah, Salt Lake City, Utah

10:45 a.m.
Genome-Wide Association Study of Peripheral Artery Disease in the Million Veteran Program
Scott M. Damrauer, MD, FAHA, University of Pennsylvania, Philadelphia, Pennsylvania

11:00 a.m.
Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism

Rob F. Walker, MPH, University of Minnesota, Minneapolis, Minnesota

11:15 a.m.
Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017

Stephen Sidney, MD, MPH, FAHA, Kaiser Permanente Northern California, Oakland, California

11:30 a.m.
Mortality Implications of Prediabetes and Diabetes in Older Adults
Olive Tang, Johns Hopkins University, Baltimore, Maryland

11:45 a.m.
Association of Low-Carbohydrate and Low-Fat Diets With Mortality Among US Adults
Yanjun Guo, PhD, MD, Harvard School of Public Health, Brookline, Massachusetts

Featured Lectures and Keynotes

The David Kritchevsky Memorial Lecture
Christopher D. Gardner, PhD, FAHA, Stanford University, Stanford, California
The David Kritchevsky Memorial Lecture was established in 2007 to honor David Kritchevsky, who made fundamental contributions to our knowledge of diet and its impact on atherosclerosis. He was one of the first scientists to study the link between cholesterol and cardiovascular risk. Subsequently, he reported on the differential effects of animal and vegetable proteins on atherosclerosis. This year’s honoree, Christopher D. Gardner, PhD, FAHA will present his lecture from 8:30-9:00 AM Thursday in the Regency Ballroom.

The Richard D. Remington Methodology Lecture
The Richard D. Remington Methodology Lecture was established in 1994 in honor of Richard Delleraine Remington, PhD, the former chair of the Council on Epidemiology and Prevention and past recipient of the American Heart Association’s Gold Heart Award and Award of Merit. He focused on the decline in funding for cardiovascular research, thereby stimulating an increase in funding. This lecture takes place from 8:30 – 9:00 AM on Friday, March 6 in the Regency Ballroom.

The William B. Kannel Memorial Lecture
Donald M. Lloyd-Jones, MD, ScM, FAHA, Northwestern University, Chicago, Illinois
The William B. Kannel Memorial Lecture was established in 2013 jointly by the Council on Epidemiology and Prevention and the American Society for Preventive Cardiology to honor Dr. Kannel’s dedication to the field of cardiovascular epidemiology. Dr. Kannel was past chairman of the Council on Epidemiology of the American Heart Association and past chief of the Section of Preventive Medicine and Epidemiology in the Department of Medicine at Boston University Medical Center. This year’s honoree, Donald M. Lloyd-Jones, MD, ScM, FAHA, will present his lecture on Friday, March 6 from 1:30 -2:00 PM in the Regency Ballroom.

8:00 AM Wednesday, Regency Ballroom
Please join us for the opening session, "Promoting Cardiovascular Health Across the Lifespan: How Do We Live Healthier, Longer?" featuring welcoming remarks from American Heart Association President Robert A. Harrington, MD, FAHA, and EPI/Lifestyle 2020 Program Committee Co-Chair Elizabeth Selvin, PhD, MPH, FAHA. Keynote Presentations will feature Matthew Gillman, MD, SM, FAHA, National Institutes of Health, North Bethesda, Maryland and Rebecca Gottesman, MD, PhD, FAHA, Johns Hopkins University, Baltimore, Maryland. Keynote presentations will be followed by three oral abstract presentations and lively audience discussion.

10:30 AM Wednesday, Regency Ballroom
Academia and Industry - Real-World Data Collaborations will feature presentations by Caroline Fox, MD, MPH, Paul Muntner, PhD, FAHA, John Concato, MD and Robert M. Califf, MD, MACC.

3:30 PM Thursday, Regency Ballroom
ASPC (American Society for Preventive Cardiology) Annual Debate: The Polypill in the US: Is it Time to Promote Pragmatism over Personalization? Ann Marie Navar, MD, PhD, will present the cons and Thomas J. Wang, MD, FAHA, will present the pros.

10:30 AM Friday, Regency Ballroom
Epidemiologic Consortia: How to Maximize Impact? Please join us for talks presented by Norrina B. Allen, PhD, MPH, FAHA, Josef Coresh, MD, PhD, FAHA, and James Meigs, MD, FAHA, followed by abstract presentations and audience discussion.

Join us for complimentary lunch* in an Expert Theater while discussing VASCEPA® (icosapent ethyl): Elevating the Standard of Care

Date: Friday, March 6, 2020
Time: 12:15 p.m. – 1:00 p.m.
Location: Regency Ballroom

Speaker: Krishnaswami Vijayaraghavan, MD, FACC, FACP, FNLA, FHFSA
Medical Director, Institute of Congestive Heart Failure
Abrazo Arizona Heart Institute and Hospital

Visit the Amarin booth #1, for more information.

*Complimentary lunch provided by The American Heart Association to the first 200 attendees

** This event is not part of the official Council on EPI Lifestyle 2020 as planned by the AHA Conference Program Committee

EPI/Lifestyle Program Information

The primary goal of EPI/Lifestyle 2020 Scientific Sessions is to promote the development and application of translational and population science to prevent heart disease and stroke and foster cardiovascular health. The Councils on Epidemiology and Prevention (EPI) and Lifestyle and Cardiometabolic Health (Lifestyle) jointly planned the EPI/Lifestyle 2020 Scientific Sessions. The sessions focus on risk factors, obesity, nutrition, physical activity, genetics, metabolism, biomarkers, subclinical disease, clinical disease, healthy populations, global health, and prevention-oriented clinical trials.

The program is designed to present new findings on:

  • Cardiovascular disease prevention trials
  • Causes and mechanisms of health factors, subclinical, and clinical cardiovascular diseases
  • Relationships of nutrition (diet) and physical activity (fitness) with cardiometabolic health
  • Relationships of obesity, diabetes, and renal disease with cardiometabolic health
  • Genetic and environmental epidemiology of cardiometabolic health
  • Effects of lifestyle interventions on cardiometabolic disease and its health factors
  • Population trends in cardiovascular diseases and their health factors
  • Global cardiovascular health

The program also will provide participants with the opportunity to learn current information about:

  • Advances in measuring diet and physical activity
  • Advances in techniques in preventive cardiology
  • Behavioral strategies to promote and sustain lifestyle modifications
  • Outcomes research and guideline development related to cardiovascular health
  • Advances in methods relevant to observational studies, clinical trials and population surveillance

The program includes presentations of new high-quality, high-impact research, organized around oral, moderated poster, and poster abstract presentations. Special translational science lectures and debates address current issues relevant to cardiometabolic health and preventive cardiology. This format maximizes the opportunities for thought-provoking multidisciplinary interactions across a wide spectrum of scientists, junior and established. The sessions are designed to enhance the careers of young and early mid-career investigators and practitioners committed to the promotion of cardiometabolic health.

The conference is designed to benefit researchers as well as public health practitioners and clinicians. The meeting should appeal to physicians, epidemiologists, dietitians, nutritional scientists, exercise physiologists, behavioral scientists, biostatisticians, pharmacists, physician assistants, nurses, school health professionals and other health scientists.

  1. Recognize opportunities to address identifiable and modifiable risk factors for ASCVD and implement the recommendations from recent guidelines on primary ASCVD prevention as well as tobacco use.
  2. Analyze the causes and health consequences of continuing disparities in ASCVD risk factors among certain racial/ethnic, gender and socioeconomic groups.
  3. Describe the relationship between psychological stress and cardiovascular health and evaluate current evidence on psychological interventions to reduce cardiovascular risk.
  4. Describe the impact of the built environment on the cardiovascular health of populations and identify research and preventative opportunities to improve such environments.
  5. Discuss current evidence and research needs related to primordial and primary ASCVD prevention in children and adolescents.
  6. Explain the concepts of Big Data and precision medicine and identify research opportunities as well as their applications in ASCVD prevention and treatment.
  7. Identify innovative areas and new skillsets for research in cardiovascular epidemiology for early-career scientists as well as the existing scientific workforce.